Industries · Precision Medicine
Precision medicine depends on robust molecular stratification. OMICS4 runs the multi-omics data generation behind patient subtyping and biomarker validation for research-use applications, via our in-house platforms.
Overview
Precision medicine depends on robust molecular stratification. OMICS4 runs the multi-omics data generation behind patient subtyping and biomarker validation for research-use applications, via our in-house platforms.
OMICS4 capabilities
Genomics, transcriptomics and clinical layers generated per cohort.
Candidate biomarkers confirmed with orthogonal, independent methods.
Reproducible sequencing workflows linked to clinical outcome.
ML models and dashboards for clinical & molecular data, delivered by GenXMap's Computational Biology & AI layer on top of our wet-lab data.
How OMICS4 adapts
No two programs run the same workflow. Here is how OMICS4 fits into what you already have in place.
Study protocols define specific endpoints, cohorts and statistical plans already locked with your team.
Sample processing plans are built around your existing protocol and endpoints, not a generic omics workflow.
Clinical and molecular data live in separate systems: EDC, LIMS, sequencing outputs.
Deliverables are formatted to integrate across your data sources into one coherent dataset.
Research-use findings must stay clearly separated from any clinical or diagnostic claim.
Reporting is scoped and labeled for research use, aligned with your regulatory positioning.
Cohorts grow over multiple recruitment waves.
Sample processing is versioned to incorporate new patient waves without reprocessing the full cohort.
Have a project in this space?